# Vir Biotechnology, Inc. (VIR): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/vir for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Vir Biotechnology, Inc. operates as an immunology company with commercialized products, dedicated to devising therapeutic solutions for the treatment and prevention of significant infectious diseases. Its pipeline features several key candidates: Sotrovimab (branded as Xevudy, or VIR-7832), a neutralizing monoclonal antibody for both treating and preventing SARS-CoV-2 infection; VIR-2218 and VIR-3434, aimed at hepatitis B virus; VIR-2482, targeting the prevention of influenza A virus; and VIR-1111, designed to prevent human immunodeficiency virus. The firm maintains a robust network of stra...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $10.57 USD |
| Market Cap | $1.79B |
| P/E (TTM) | — |
| EPS (TTM) | −$1.86 |
| 52-Week Range | $4.82 – $12.00 |
| Dividend Yield (TTM) | — |

## Dividend

VIR has no dividend payment history in our records.

## Frequently Asked Questions

### What does Vir Biotechnology, Inc. do?

Vir Biotechnology, Inc. (VIR) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is VIR's market cap?

Vir Biotechnology, Inc. (VIR) has a market capitalization of approximately $1.79 billion, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does VIR pay a dividend?

No, Vir Biotechnology, Inc. (VIR) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is VIR profitable?

Vir Biotechnology, Inc. (VIR) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has VIR ever paid a dividend?

No. Dividend Data's records show no dividend payments from Vir Biotechnology, Inc. (VIR). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/vir
- Dividend history & safety: https://www.dividenddata.com/stocks/vir/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/vir/earnings
- Financial statements: https://www.dividenddata.com/stocks/vir/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/vir/valuation
- Peer comparison: https://www.dividenddata.com/stocks/vir/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.